ConvaTec Group Plc (LON: CTEC)

Market Cap	4.80B
Revenue (ttm)	1.69B
Net Income (ttm)	102.72M
Shares Out	2.05B
EPS (ttm)	0.05
PE Ratio	47.04
Forward PE	22.57
Dividend	0.06 (0.03%)
Ex-Dividend Date	Apr 25, 2024

Volume	2,537,735
Open	233.20
Previous Close	236.40
Day's Range	n/a
52-Week Range	195.10 - 295.20
Beta	0.60
Analysts	n/a
Price Target	2.79 (-98.81%)
Earnings Date	Jul 30, 2024

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammato...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 10,136
• Stock Exchange: London Stock Exchange
• Ticker Symbol: CTEC

Financial Performance

In 2023, ConvaTec Group's revenue was $2.14 billion, an increase of 3.37% compared to the previous year's $2.07 billion. Earnings were $130.30 million, an increase of 107.15%.

Financial numbers in USD